forxiga glp 1 Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors Among Patients with Type Diabetes: A Nationwide Register-Based Cohort Study Farxiga (Dapagliflozin) – Buy Online
Description
Facts about treatment and pharmacology here.
The primary outcome was change in HbA1c from baseline
P=0.001] and whole-body bone mineral density [MD0.02 kg/m2 (95% CI,0.04 to0.00)
Whilst all GLP-1RAs use has increased, the largest change was seen in patients using tirzepatide and semaglutide ([figure 1B][1])
(Sun F et coll
%25201.png)
this twincretin approach targets two incretin pathways instead of one
